Scinvivo
PrivateLast Round
VC Round
Feb 21, 2024
Total Funding Raised
$1.5M
Company Overview
Scinvivo operates in Healthcare & Life Sciences and is based in Eindhoven. Its latest recorded funding round was a VC Round in February 2024.
Scinvivo is a medical technology company that develops optical coherence tomography (OCT) imaging platforms for the diagnosis and staging of bladder cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scinvivo Comparables
Compare Scinvivo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thericon GmbH | 81% | |
| Imagin Medical Inc. | 79% | |
| Multi4 Medical | 75% |
For institutional investors. Book with your work email.
Scinvivo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 21, 2024 | ||||
| Seed | Mar 10, 2022 | ||||
| Debt | Nov 28, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Scinvivo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovatiefonds Noord-Holland | Debt, Seed |
| NLC Health Ventures | VC Round |
| Netherlands Enterprise Agency | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2026
Grew 42% QoQ from 12 to 17 employees.
- May 4, 2025
Grew 29% QoQ, from 14 to 18 employees.
For institutional investors. Book with your work email.
Scinvivo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scinvivo's valuation, stock price, and market status.
Is Scinvivo a public or private company?
Scinvivo is a private company.
What is the current stock price of Scinvivo?
Scinvivo is a private company, so its shares have no public market price. Caplight tracks Scinvivo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scinvivo worth (valuation)?
Valuation information for Scinvivo is not publicly available.
Can I buy Scinvivo stock?
Scinvivo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scinvivo's last funding round?
Scinvivo's most recent funding round was VC Round on February 21, 2024.
Who are the main investors in Scinvivo?
Key investors in Scinvivo include Innovatiefonds Noord-Holland, NLC Health Ventures, Netherlands Enterprise Agency.
Will Scinvivo IPO soon?
No public IPO plans have been announced for Scinvivo.
How can I track Scinvivo secondary market activity?
Caplight tracks bids, offers, and trades in Scinvivo's shares on secondary markets.